Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients

Pemetrexed, one of the most commonly used drugs in advanced non–small cell lung cancer (NSCLC) therapies, often leads to various therapeutic responses in patients. These therapeutic responses to pemetrexed, including adverse drug reactions (ADRs) and its intended therapeutic effects, have been demon...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Xiaoqing Zhang, Di Zhang, Lihua Huang, Guorong Li, Luan Chen, Jingsong Ma, Mo Li, Muyun Wei, Wei Zhou, Chenxi Zhou, Jinhang Zhu, Zhanhui Wang, Shengying Qin
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019-08-01
Serija:Frontiers in Pharmacology
Teme:
pemetrexed
non–small cell lung cancer
adverse drug reactions
therapeutic effects
single nucleotide polymorphism
biomarker
Online pristup:https://www.frontiersin.org/article/10.3389/fphar.2019.00944/full
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items